Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Sci. STKE, 30 September 2003
Vol. 2003, Issue 202, p. tw376
[DOI: 10.1126/stke.2003.202.tw376]


LIGAND-RECEPTOR INTERACTION Nature's Design for a Versatile Interaction Domain

The gp130 protein is a shared receptor subunit that binds to at least 10 different cytokines. Boulanger et al. were therefore curious what features of gp130 would allow interaction with such a range of structurally dissimilar cytokines. Comparison of various cytokine-gp130 crystal structures showed that in fact the interactions predominantly occur through a single region of gp130. Furthermore, a crystal structure of the cytokine leukemia inhibitory factor (LIF) with the cytokine binding region of gp130 showed this region of the gp130 protein to be unusually rigid. Thus, the authors argue that gp130 is unlikely to accommodate its multiple ligands through conformational changes. Further analysis of the interaction by computational alanine scanning mutagenesis and thermodynamic measurements made by isothermal titration calorimetry support what the authors call a "thermodynamic plasticity" of the interaction site. Depending on the nature of the ligand, the interaction site of gp130 offers either polar interactions or hydrophobic interactions that favor binding in a manner that is relatively insensitive to ligand structure. Release of bound water molecules appears to contribute favorable gain in entropy to the binding reactions. Some gp130-interacting cytokines interact through another domain with a separate α-receptor subunit. In this case, the interaction mechanism is very different: It is sensitive to ligand structure and entropically unfavorable, relying primarily on hydrogen bonds and salt bridges. The authors note that the gp130 system offers a potential therapeutic target for a large range of physiological processes, and better understanding of its multiple interactions may allow strategies that specifically alter a particular action of this multifaceted signaling molecule.

M. J. Boulanger, A. J. Bankovich, T. Kortemme, D. Baker, K. C. Garcia, Convergent mechanisms for recognition of divergent cytokines by the shared signaling receptor gp130. Mol. Cell 12, 577-589 (2003). [Online Journal]

Citation: Nature's Design for a Versatile Interaction Domain. Sci. STKE 2003, tw376 (2003).

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882